is the most-cited primary reference
Because it is water-soluble, excess is typically excreted through the kidneys rather than accumulating to toxic levels, making supplementation generally safe even at high therapeutic doses
National Library of Medicine) Subcutaneous (SQ) injections: technique, site selection, and procedure Frontiers in Pharmacology DSIP fusion peptides crossing the blood-brain barrier and efficacy in insomnia models European Neurology (PubMed) Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic pain episodes European Neurology (PubMed) DSIP in the treatment of withdrawal syndromes from alcohol and opiates Johns Hopkins Arthritis Center How to give a subcutaneous injection: site rotation and best practices Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
Blood flow and angiogenesis: One of the most promising potential benefits of BPC-157 is its angiogenic effect, or its ability to promote the formation of new blood vessels, which may help improve vasculature and blood flow
Only Epitalon, a peptide that has been employed to alleviate insomnia, was rejected by the panel
These two compounds combine synergistically to enhance the body's natural healing mechanisms, potentially leading to improved recovery times from injuries or surgical procedures [1]